Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration (Q80538011)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marcella Visentini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Massimo Fiorilli

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Isabella Quinti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Annarosa Soresina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Giuseppe Spadaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrea Matucci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ifigeneia Sfika

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Helene Martini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Federica Borghese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrea Guerra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Vultaggio Alessandra

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alessandro Plebani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

263-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214651%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10875-007-9169-9

1 January 2020

exact match

0 references

cites work

Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency

1 reference

12 December 2020

Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy

1 reference

12 December 2020

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries

1 reference

12 December 2020

The use of intravenous immune globulin in immunodeficiency diseases

1 reference

12 December 2020

Intrainfusion and postinfusion adverse events related to intravenous immunoglobulin therapy in immunodeficiency states.

1 reference

12 December 2020

Adverse events associated with intravenous immunoglobulin therapy

1 reference

12 December 2020

Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases

1 reference

12 December 2020

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

1 reference

12 December 2020

Adverse effects of intravenous immunoglobulin

1 reference

12 December 2020

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

1 reference

12 December 2020

Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.

1 reference

12 December 2020

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy

1 reference

12 December 2020

A novel immunodeficiency characterized by the exclusive presence of transitional B cells unresponsive to CpG

1 reference

12 December 2020

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin

1 reference

12 December 2020

Side-effects of intravenous immune globulins

1 reference

12 December 2020

Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy

1 reference

12 December 2020

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

1 reference

12 December 2020